Indeed, studies from an ESCC animal model revealed that IL-18 deficiency can down-regulate local NK cell anti-tumor immunity by decreasing their IFN-γ production, suggesting that exogenous IL-18 supplementation has potential to delay EC development (27). This evidence concerns the gene IL18 and esophageal squamous cell carcinoma.